Your browser doesn't support javascript.
loading
Sexual behavior and medication adherence in men who have sex with men participating in a pre-exposure prophylaxis study of combinations of Maraviroc, Tenofovir Disoproxil Fumarate and/or Emtricitabine (HPTN 069/ACTG 5305).
Mayer, Kenneth H; Yuhas, Krista; Amico, K Rivet; Wilkin, Timothy; Landovitz, Raphael J; Richardson, Paul; Marzinke, Mark A; Hendrix, Craig W; Eshleman, Susan H; Cottle, Leslie M; Marcus, Cheryl; Chege, Wairimu; Rinehart, Alex R; Rooney, James F; Andrew, Philip; Salata, Robert A; Magnus, Manya; Farley, Jason E; Liu, Albert Y; Frank, Ian; Ho, Ken; Santana, Jorge; Stekler, Joanne D; Chen, Ying Q; McCauley, Marybeth; Gulick, Roy M.
Afiliação
  • Mayer KH; The Fenway Institute, Fenway Health, Harvard Medical School, Harvard University, 1340 Boylston St, 02215, Boston, MA, United States. kmayer@fenwayhealth.org.
  • Yuhas K; Statistical Center for HIV/AIDS Research (SCHARP), Fred Hutchinson Cancer Research Center, Seattle, WA, United States.
  • Amico KR; University of Michigan School of Public Health, Ann Arbor, MI, United States.
  • Wilkin T; Weill Cornell Medicine, New York, NY, United States.
  • Landovitz RJ; UCLA Center for Clinical AIDS Research & Education, Los Angeles, CA, United States.
  • Richardson P; Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States.
  • Marzinke MA; Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States.
  • Hendrix CW; Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States.
  • Eshleman SH; Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States.
  • Cottle LM; , Seagen, Bothell, WA, United States.
  • Marcus C; HIV Clinical Trials Unit, University of North Carolina, Chapel Hill, NC, United States.
  • Chege W; Clinical Prevention Research Branch, Prevention Sciences Program, Division of AIDS, National Institute of Allergy and Infectious Diseases, Bethesda, MD, United States.
  • Rinehart AR; Global HIV Prevention Strategy, ViiV Healthcare - Research Triangle Park, Research Triangle Park, NC, United States.
  • Rooney JF; Medical Affairs, Gilead Sciences, 12. FHI 360, Foster City, Durham, CA, NC, United States.
  • Andrew P; , FHI 360, Durham, NC, United States.
  • Salata RA; Department of Medicine, Case Western Reserve University, Cleveland, OH, United States.
  • Magnus M; Milken Institute School of Public Health, George Washington University, Washington, DC, United States.
  • Farley JE; Johns Hopkins University School of Medicine, Baltimore, MD, United States.
  • Liu AY; San Francisco Department of Public Health, Bridge HIV, San Francisco, CA, United States.
  • Frank I; Hospital of the University of Pennsylvania, Philadelphia, PA, United States.
  • Ho K; Department of Medicine, University of Pittsburgh, Pittsburgh, PA, United States.
  • Santana J; University of Puerto Rico, San Juan, Puerto Rico.
  • Stekler JD; University of Washington School of Medicine, Seattle, WA, United States.
  • Chen YQ; Statistical Center for HIV/AIDS Research (SCHARP), Fred Hutchinson Cancer Research Center, Seattle, WA, United States.
  • McCauley M; , FHI 360, Durham, NC, United States.
  • Gulick RM; Weill Cornell Medicine, New York, NY, United States.
AIDS Behav ; 26(12): 4107-4114, 2022 Dec.
Article em En | MEDLINE | ID: mdl-35687192
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Infecções por HIV / Fármacos Anti-HIV / Profilaxia Pré-Exposição / Minorias Sexuais e de Gênero Limite: Female / Humans / Male Idioma: En Ano de publicação: 2022
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Infecções por HIV / Fármacos Anti-HIV / Profilaxia Pré-Exposição / Minorias Sexuais e de Gênero Limite: Female / Humans / Male Idioma: En Ano de publicação: 2022